El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
Pfizer
Abierto
SectorSalud
26.76 -1.4
Resumen
Variación precio
24h
Mínimo
26.63
Máximo
27.33
Ingresos | -5.2B -1.6B |
|---|---|
Ventas | 903M 18B |
P/B Media del Sector | 19.713 61.417 |
BPA | 0.66 |
Rentabilidad por dividendo | 6.36 |
Margen de beneficio | -9.387 |
Empleados | 75,000 |
EBITDA | -4.9B 756M |
Recomendaciones | Neutral |
|---|---|
Estimación a 12 meses | +6.3% upside |
Rentabilidad por dividendo Media del Sector | 6.36% 2.40% |
|---|---|
Próximas Ganancias | 28 abr 2026 |
Próxima Fecha de Ex Dividendo | 8 may 2026 |
Capitalización de Mercado | 868M 152B |
|---|---|
Apertura anterior | 28.16 |
Cierre anterior | 26.76 |
Noticias sobre sentimiento de mercado
By Acuity
47%
53%
139 / 351 Clasificación en Healthcare
Puntuación técnica
By Trading Central
Confianza
Bullish Evidence
Pfizer Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Pfizer Esperado
Precio Objetivo
By TipRanks
6.3% repunte
Estimación a 12 meses
Media 28.87 USD 6.3%
Máximo 35.46 USD
Mínimo 25 USD
De acuerdo con 21 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.
Sentimiento
By Acuity
139 / 351 Clasificación en Salud
Noticias sobre sentimiento de mercado
Coyuntura alcista
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Pfizer
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Live chat